Profile
William Fricker worked as a Controller at Immunomedics, Inc. from 2018 to 2020.
He was the Chief Financial Officer at NRX Pharmaceuticals, Inc. in 2021.
In 2022, he worked as the Chief Financial Officer at Eleison Pharmaceuticals, Inc. Mr. Fricker also held a position as VP, Global Controller & Chief Accounting Officer at J.
M.
Huber Micropowders, Inc.
Former positions of William Fricker
| Companies | Position | End |
|---|---|---|
Eleison Pharmaceuticals, Inc.
 Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Director of Finance/CFO | 2022-12-31 |
| NRX PHARMACEUTICALS, INC. | Director of Finance/CFO | 2021-08-29 |
| IMMUNOMEDICS, INC. | Comptroller/Controller/Auditor | 2020-09-30 |
J. M. Huber Micropowders, Inc.
 J. M. Huber Micropowders, Inc. Chemicals: SpecialtyProcess Industries Part of J. M. Huber Corp., J. M. Huber Micropowders, Inc. is a company that manufactures chemicals and minerals. The company is based in Edison, NJ. The CEO of the company is Matthew O'Brien. | Comptroller/Controller/Auditor | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NRX PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
J. M. Huber Micropowders, Inc.
J. M. Huber Micropowders, Inc. Chemicals: SpecialtyProcess Industries Part of J. M. Huber Corp., J. M. Huber Micropowders, Inc. is a company that manufactures chemicals and minerals. The company is based in Edison, NJ. The CEO of the company is Matthew O'Brien. | Process Industries |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- William Fricker
